These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Paterson AD; Rommens JM; Bharaj B; Blavignac J; Wong I; Diamandis M; Waye JS; Rivard GE; Hayward CP Blood; 2010 Feb; 115(6):1264-6. PubMed ID: 20007542 [TBL] [Abstract][Full Text] [Related]
4. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Maurer-Spurej E; Kahr WH; Carter CJ; Pittendreigh C; Cameron M; Cyr TD Platelets; 2008 Aug; 19(5):342-51. PubMed ID: 18791940 [TBL] [Abstract][Full Text] [Related]
5. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Diamandis M; Paterson AD; Rommens JM; Veljkovic DK; Blavignac J; Bulman DE; Waye JS; Derome F; Rivard GE; Hayward CP Blood; 2009 Feb; 113(7):1543-6. PubMed ID: 18988861 [TBL] [Abstract][Full Text] [Related]
6. [Determination of urokinase in the urine using thrombelastography and the fibrin-plate test]. Stein G; Lindner M; Schultz C; Neumann W Z Gesamte Inn Med; 1974 Dec; 29(24):1027-30. PubMed ID: 4458319 [No Abstract] [Full Text] [Related]
7. [Product E, urokinase and uropepsinogen in the urine of diabetic children]. Symonides-Lawecka A; Galczak W; Olech K; Wysocki M Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753 [No Abstract] [Full Text] [Related]
8. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B. Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743 [TBL] [Abstract][Full Text] [Related]
9. The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Gach K; Szemraj J; Fichna J; Piestrzeniewicz M; Delbro DS; Janecka A Chem Biol Drug Des; 2009 Oct; 74(4):390-6. PubMed ID: 19691469 [TBL] [Abstract][Full Text] [Related]
10. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)]. Wakayama Y Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728 [No Abstract] [Full Text] [Related]
11. The urokinase system in patients with intermittent and persistent allergic rhinitis. Kasperska-Zajac A; Brzoza Z; Rogala B Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910 [TBL] [Abstract][Full Text] [Related]
12. [Determination of kallikrein excretion in the urine]. Klauser RJ; Blümel G Med Welt; 1980 Apr; 31(14):521-2. PubMed ID: 6154862 [No Abstract] [Full Text] [Related]
13. Bleeding risks associated with inheritance of the Quebec platelet disorder. McKay H; Derome F; Haq MA; Whittaker S; Arnold E; Adam F; Heddle NM; Rivard GE; Hayward CP Blood; 2004 Jul; 104(1):159-65. PubMed ID: 15026313 [TBL] [Abstract][Full Text] [Related]
14. Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer. Milanese G; Dellabella M; Fazioli F; Pierpaoli E; Polito M; Siednius N; Montironi R; Blasi F; Muzzonigro G J Urol; 2009 Mar; 181(3):1393-400. PubMed ID: 19157433 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of urokinase-type plasminogen activator genotypes in gastric cancer. Wu CY; Wu MS; Chen YJ; Chen HP; Chen CJ; Chang CS; Lin JT Hepatogastroenterology; 2008; 55(86-87):1890-4. PubMed ID: 19102416 [TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients. De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A; Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353 [TBL] [Abstract][Full Text] [Related]
17. Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients. Saliba AN; Ferrer A; Gangat N; Pruthi RK; Tefferi A; Higgins A; Bezerra ED; Buglioni A; Salama ME; Klee EW; Pinto E Vairo F; Mangaonkar A; Majerus J; Chen D; Patnaik MM Br J Haematol; 2020 Sep; 190(5):e316-e320. PubMed ID: 32567678 [No Abstract] [Full Text] [Related]